Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Short-Term Debt issuances (2018 - 2019)

Health Catalyst's Short-Term Debt issuances history spans 2 years, with the latest figure at $47.2 million for Q1 2019.

  • For Q1 2019, Short-Term Debt issuances changed N/A year-over-year to $47.2 million; the TTM value through Dec 2019 reached $47.2 million, changed N/A, while the annual FY2019 figure was $47.2 million, 374.06% up from the prior year.
  • Short-Term Debt issuances reached $47.2 million in Q1 2019 per HCAT's latest filing, up from $10.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $47.2 million in Q1 2019 to a low of $10.0 million in Q4 2018.